نمایش پرونده ساده آیتم

dc.contributor.authorGhafourian, T
dc.contributor.authorDearden, JC
dc.date.accessioned2018-08-26T08:31:29Z
dc.date.available2018-08-26T08:31:29Z
dc.date.issued2000
dc.identifier10.1211/0022357001774435
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/52159
dc.description.abstractHydrogen-bonding, important in drug-receptor interactions, also determines the solubility and partitioning of drugs between phases. It is, therefore, important to incorporate the effects of hydrogen-bonding in studies of quantitative structure-activity relationships (QSAR). In this study the atomic charge on the most positively charged hydrogen atom in a molecule and the energy of the lowest unoccupied molecular orbital (LUMO) have been used as a measure of hydrogen-bond-donor capacity. For several hydrogen-bonding acids the Mulliken atomic charges and the energy of the LUMO produced by use of three semiempirical methods, AM1, PM3 and MNDO, and MNDO electrostatic-potential-derived atomic charges, have been compared in correlations with solvatochromic hydrogen-bonding acidity (Sigma alpha(2)(H)). Atomic charges and LUMO energies, particularly those calculated by use of the AM1 and MNDO methods, were found to correlate well with Sigma alpha(2)(H). They were also found to be good models of hydrogen-bonding in QSAR correlations.
dc.language.isoEnglish
dc.relation.ispartofJOURNAL OF PHARMACY AND PHARMACOLOGY
dc.titleThe use of atomic charges and orbital energies as hydrogen-bonding-donor parameters for QSAR studies: Comparison of MNDO, AM1 and PM13 methods
dc.typeArticle
dc.citation.volume52
dc.citation.issue6
dc.citation.spage603
dc.citation.epage610
dc.citation.indexWeb of science
dc.identifier.DOIhttps://doi.org/10.1211/0022357001774435


فایلهای درون آیتم

فایلهاسایزفرمتنمایش

هیچ فایل مرتبطی وجود ندارد

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم